Latest Commercialization News

AVITA Medical’s Q2 2025 update reveals a temporary setback in RECELL demand due to Medicare reimbursement delays, offset by strong revenue growth and promising clinical data. The company anticipates recovery and renewed growth in the second half of the year.

AVITA Medical reported a 21% increase in Q2 commercial revenue to $18.4 million and narrowed its net loss, yet faces a reimbursement hurdle that forced a downward revision of full-year guidance. The company highlights clinical progress and strategic board appointments as it navigates payment challenges.

Fortescue has secured a landmark RMB 14.2 billion syndicated term loan, marking the first such facility by an Australian corporate and underscoring its deepening ties with China to support its decarbonisation goals.

VRX Silica Limited has secured approval for its Mining Proposal at the Arrowsmith North Silica Sand Project, marking a pivotal step toward production in a globally significant silica sand deposit.

QBE Insurance Group reported a robust half-year performance with a 28% rise in adjusted net profit and solid premium growth, underpinning a confident outlook for 2025.

Celsius Resources reports steady progress on the MCB Copper-Gold Project feasibility and engineering design, while engaging multiple parties in financing discussions including a new memorandum of understanding with Kiri Industries.

Neometals has agreed to sell its 50% stake in the lithium-ion battery recycling joint venture Primobius to SMS Group for €5 million upfront plus future royalties, marking a strategic pivot away from capital-intensive projects.

VDM Group remains suspended from ASX trading amid a legal dispute over its Angolan joint ventures, while pivoting towards new critical minerals opportunities in Australia.

Elanor Commercial Property Fund has received an unsolicited off-market takeover offer from the Lederer Group, prompting the formation of an Independent Board Committee to evaluate the proposal and advise securityholders.

Lodestar Minerals launches a pro-rata bonus issue of Loyalty Options to existing shareholders, offering potential future capital without immediate dilution. The options are exercisable at $0.01 until August 2029, aiming to reward long-term investors and support company growth.

Papyrus Australia appoints Daniel Schmidt as CEO to lead its transition from R&D to commercial operations, alongside a strategic restructure to support growth.

Nanoveu Limited has completed the final tranche of its $3.02 million capital raising, with Chairman Dr David Pevcic investing $400,000 following shareholder approval. This funding round bolsters Nanoveu’s push in advanced semiconductor and 3D visualization technologies.